Patents by Inventor Raj Kishore

Raj Kishore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230324279
    Abstract: A corrosion detection system includes a wire disposed in a groove extending circumferentially around an exterior surface of a pipe, the pipe comprising a pipe wall and a pipe liner that lines an inside surface of the pipe wall. The corrosion detection system also includes a sensor electrically coupled to the wire. The sensor is configured to generate a voltage in the wire, and detect a change in a property of the wire caused by exposure of the wire to a corrosive fluid that is present within the pipe but outside the pipe liner.
    Type: Application
    Filed: April 6, 2023
    Publication date: October 12, 2023
    Inventors: Raj Kishore Mishra, David Yanik, Ashutosh Singh, Bradley Allen
  • Patent number: 11672830
    Abstract: The invention provides one or more of miR-290 family and Lin28a modified cardiac progenitor cell based therapies for the treatment of myocardial infarction. Exosomes derived from one or more of miR-290 family and Lin28a modified cardiac progenitor cells can also be used in cardiac therapy.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: June 13, 2023
    Assignee: Temple University-Of The Commonwealth System of Higher Education
    Inventors: Mohsin Khan, Raj Kishore
  • Patent number: 11292659
    Abstract: Disclosed is a packing system for a slide of an aircraft evacuation system, the packing system having: a rigid packboard having a first side end and a second side end that opposes the first side end; a first valise flap having a first outer end and a first inner end, the first outer end connected to the first side end of the rigid packboard; a second valise flap having a second outer end and a second inner end, the second outer end connected to the second side end of the rigid packboard; and lacing for tying together the first inner end of the first valise flap and the second inner end of the second valise flap, wherein the first valise flap and the second valise flap are formed of a heat shrink material.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: April 5, 2022
    Assignee: GOODRICH CORPORATION
    Inventors: Mohinder Saini, Raj Kishore, Sandesh Swamidas, Ankita Choudhury
  • Publication number: 20210179341
    Abstract: Disclosed is a packing system for a slide of an aircraft evacuation system, the packing system having: a rigid packboard having a first side end and a second side end that opposes the first side end; a first valise flap having a first outer end and a first inner end, the first outer end connected to the first side end of the rigid packboard; a second valise flap having a second outer end and a second inner end, the second outer end connected to the second side end of the rigid packboard; and lacing for tying together the first inner end of the first valise flap and the second inner end of the second valise flap, wherein the first valise flap and the second valise flap are formed of a heat shrink material.
    Type: Application
    Filed: February 7, 2020
    Publication date: June 17, 2021
    Inventors: Mohinder Saini, Raj Kishore, Sandesh Swamidas, Ankita Choudhury
  • Publication number: 20200323924
    Abstract: The invention provides one or more of miR-290 family and Lin28a modified cardiac progenitor cell based therapies for the treatment of myocardial infarction. Exosomes derived from one or more of miR-290 family and Lin28a modified cardiac progenitor cells can also be used in cardiac therapy.
    Type: Application
    Filed: April 17, 2017
    Publication date: October 15, 2020
    Inventors: Mohsin Khan, Raj Kishore
  • Publication number: 20180008641
    Abstract: The present invention relates to compositions and methods useful for treating ischemic injury. In one embodiment, the present invention uses an inhibitor of miR-375 in a cell to enhance its survival.
    Type: Application
    Filed: November 18, 2015
    Publication date: January 11, 2018
    Inventors: Raj Kishore, Venkata Naga Srikanth Garikipati
  • Publication number: 20140134139
    Abstract: Disclosed herein is a reprogrammed endothelial progenitor cell, said cell comprises a bone marrow-derived cell expressing the CD34+ marker and at least one cardiomyocyte-specific gene, as well as methods for preparing and using the same for cardiac regenerative medicine.
    Type: Application
    Filed: November 7, 2013
    Publication date: May 15, 2014
    Applicant: NORTHWESTERN UNIVERSITY
    Inventors: Raj Kishore, Melissa A. Thal
  • Publication number: 20100150841
    Abstract: As described below, the present invention features compositions and methods for increasing TNFR2/p75 receptor signaling to reduce inflammation. Methods for increasing TNFR2/p75 expression or signaling may also be used to increase the survival of resident cells or transplanted stem cells (e.g., bone marrow derived or peripheral blood derived stem cells) in a damaged tissue.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 17, 2010
    Applicant: CARITAS ST. ELIZABETH MEDICAL CENTER OF BOSTON, IN
    Inventors: David A. Goukassian, Raj Kishore
  • Publication number: 20100135970
    Abstract: As described below, the present invention features methods for reprogramming somatic cells and related therapeutic compositions and methods.
    Type: Application
    Filed: October 26, 2007
    Publication date: June 3, 2010
    Applicant: Caritas St. Elizabeth Medical Center of Boston, In
    Inventors: Raj Kishore, Douglas W. Losordo
  • Publication number: 20040105860
    Abstract: Disclosed are compositions and methods for modulating endothelial cells (ECs) in a mammal. Practice of the invention generally involves changing activity of the ezrin cytoskeletal protein sufficient to increase or decrease proliferation of the cells. Also disclosed are useful screens for detecting agents capable of modulating ezrin activity. The invention has a variety of useful applications including use in the treatment of diseases associated with unsatisfactory EC proliferation.
    Type: Application
    Filed: August 1, 2003
    Publication date: June 3, 2004
    Inventors: Douglas W. Losordo, Raj Kishore